trial · primary record
Recombinant Human Proteoglycan 4
Sjögren's Syndrome
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-03 |
| Primary endpoint | To assess the efficacy of rhPRG4 by looking at the frequency of patients attaining complete resolution of total corneal staining with fluorescein (Oxford Scale) at Day 28 |
| Registry ID | NCT07118241 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:32.746Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07118241
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.